Model-Based Cost–Utility Analysis of Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Treatment Induced Anaemia in the UK NHS

Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2316
https://www.valueinhealthjournal.com/article/S1098-3015(14)04246-6/fulltext
Section Title : Disease-Specific Studies
Section Order : 1768
First Page : A641
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04246-6&doi=10.1016/j.jval.2014.08.2316
HEOR Topics :
Tags :
Regions :